{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:32:43Z","timestamp":1786653163437,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Pharmacol"],"published-print":{"date-parts":[[2015]]},"DOI":"10.4103\/0253-7613.150360","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T02:42:33Z","timestamp":1422585753000},"page":"90","source":"Crossref","is-referenced-by-count":5,"title":["A comparison of enoxaparin with unfractionated heparins in patients with coronary heart disease in an emergency department in rural South Indian tertiary care teaching hospital"],"prefix":"10.4103","volume":"47","author":[{"given":"Akram","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himani","family":"Asani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Jagadeesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Parimalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Selvamuthukumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0253-7613.150360-1","first-page":"9","volume-title":"The Economic impact of non-communicable diseases on households in India","author":"Engelgau","year":"2012","journal-title":"Global Health"},{"key":"key-10.4103\/0253-7613.150360-2","first-page":"807","volume-title":"Burden of non-communicable diseases in South Asia","author":"Ghaffar","year":"2004","journal-title":"BMJ"},{"key":"key-10.4103\/0253-7613.150360-3","unstructured":"Walker R, Whittlesea C. Clinical Pharmacy and Therapeutics. 4 th ed. \u200aChurchill Livingstone Elsevier Ltd. 2008. p. 280, 336-7."},{"key":"key-10.4103\/0253-7613.150360-4","unstructured":"Huffman MD. Center for Chronic Disease Control, Coronary Heart Disease in India . Available from: http:\/\/www.sancd.org\/uploads\/pdf\/factsheet_CHD.pdf. [Last accessed on 2013 Mar 30]."},{"key":"key-10.4103\/0253-7613.150360-5","first-page":"16","volume-title":"Epidemiology and causation of coronary heart disease and stroke in India","author":"Gupta","year":"2008","journal-title":"Heart"},{"key":"key-10.4103\/0253-7613.150360-6","first-page":"3547","volume-title":"Cardiovascular disease in the developing world and its cost-effective management","author":"Gaziano","year":"2005","journal-title":"Circulation"},{"key":"key-10.4103\/0253-7613.150360-7","first-page":"1498","volume-title":"Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"key-10.4103\/0253-7613.150360-8","unstructured":"Sharma S, Sethi GR, Gupta U. Standard Treatment Guidelines - A Manual for Medical Therapeutics. 3 rd ed. New Delhi: Delhi Society for Promotion of Rational Use of Drugs, B I Publishing House Pvt. Ltd.; 2009. p. 116-24."},{"key":"key-10.4103\/0253-7613.150360-9","first-page":"1030","volume-title":"Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: A randomized controlled trial","author":"Misra","year":"2012","journal-title":"Eur J Neurol"},{"key":"key-10.4103\/0253-7613.150360-10","first-page":"3097","volume-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: Executive summary: A report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons","author":"Fihn","year":"2012","journal-title":"Circulation"},{"key":"key-10.4103\/0253-7613.150360-11","first-page":"703","volume-title":"A comparative study of dalteparin and unfractionated heparin in patients with unstable angina pectoris","author":"Amane","year":"2011","journal-title":"Indian J Pharmacol","ISSN":"https:\/\/id.crossref.org\/issn\/0253-7613","issn-type":"print"},{"key":"key-10.4103\/0253-7613.150360-12","first-page":"336","volume-title":"Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement.Enoxaparin Clinical Trial Group","author":"Comp","year":"2001","journal-title":"J Bone Joint Surg Am"},{"key":"key-10.4103\/0253-7613.150360-13","first-page":"677","volume-title":"A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis","author":"Levine","year":"1996","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0253-7613.150360-14","first-page":"682","volume-title":"Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home.The Tasman Study Group","author":"Koopman","year":"1996","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0253-7613.150360-15","first-page":"46","volume-title":"Comparison of enoxaparin and unfractionated heparin in coronary angioplasty","author":"Korovesis","year":"2005","journal-title":"Hellenic J Cardiol"},{"key":"key-10.4103\/0253-7613.150360-16","first-page":"259","volume-title":"The management of heparin-induced thrombocytopenia","author":"Keeling","year":"2006","journal-title":"Br J Haematol"},{"key":"key-10.4103\/0253-7613.150360-17","first-page":"2310","volume-title":"The search for replacements for unfractionated heparin","author":"Antman","year":"2001","journal-title":"Circulation"},{"key":"key-10.4103\/0253-7613.150360-18","first-page":"294","volume-title":"Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: Beneficial effects of enoxaparin.French Investigators of the ESSENCE Trial","author":"Montalescot","year":"1998","journal-title":"Circulation"},{"key":"key-10.4103\/0253-7613.150360-19","first-page":"293","volume-title":"A rise of troponin and\/or von Willebrand factor over the first 48 h is associated with a poorer 1-year outcome in unstable angina patients","author":"Montalescot","year":"2000","journal-title":"Int J Cardiol"},{"key":"key-10.4103\/0253-7613.150360-20","first-page":"110","volume-title":"Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina","author":"Montalescot","year":"2000","journal-title":"J Am Coll Cardiol"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:32:38Z","timestamp":1786649558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0253-7613.150360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"alternative-id":["150360"],"URL":"https:\/\/doi.org\/10.4103\/0253-7613.150360","relation":{},"ISSN":["0253-7613"],"issn-type":[{"value":"0253-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]}}}